Skip to main content
Premium Trial:

Request an Annual Quote

OncoPlexDx Achieves CAP Accreditation for Clinical Lab

NEW YORK (GenomeWeb News) – OncoPlex Diagnostics said today that it has received certification of accreditation from the College of American Pathologists for its clinical laboratory facility.

The company's lab offers mass spec-based quantitation of oncoproteins in tissue, providing clinicians with protein expression data to guide patient treatment decisions.

CAP accreditation is an internationally recognized certification with standards that typically exceed standard regulatory requirements. OncoPlex is now both CAP-accredited and CLIA-certified for clinical processing of formalin-fixed, paraffin-embedded cancer tissue using selected-reaction monitoring mass spectrometry.

"Clinicians ordering our assays can have confidence that the results received are of the highest quality possible," OncoPlex CEO Jon Burrows said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.